Özkan, Semra, and Deniz Gezer. 2025. “The Impact of Dapagliflozin on FIB-4 Index over 2 Years in Patients With Type 2 Diabetes Mellitus”. The European Research Journal 11 (4): 676-82. https://doi.org/10.18621/eurj.1631079.